Receive our newsletter – data, insights and analysis delivered to you
June 19, 2016

New analysis reveals Brexit would affect UK pharmaceutical industry

An analysis by pharmaceutical and life sciences recruitment consultancy NonStop Recruitment has revealed that Britain's exit (Brexit) from the European Union (EU) entails the possibility to directly damage the UK pharmaceutical industry.

By Lopamudra Roy

An analysis by pharmaceutical and life sciences recruitment consultancy NonStop Recruitment has revealed that Britain’s exit (Brexit) from the European Union (EU) entails the possibility to directly damage the UK pharmaceutical industry.

If the UK exits from the EU, the pharmaceutical industry of the country would still have to follow regulations to sell in the single market, though they would not have any say in what these regulations were.

NonStop Pharma team leader Matt Beedle said: "From our analysis and the many others that have been released, it’s clear that the pharmaceutical and life sciences fields would be directly impacted in the case of a Brexit.

"Yes, the situation isn’t perfect at the moment, however, the outlook would still be far worse if we were to vote leave."

"From our analysis and the many others that have been released, it’s clear that the pharmaceutical and life sciences fields would be directly impacted in the case of a Brexit."

On leaving the EU, the country would also lose out on the greater patent protection, as well as support for research that it currently receives from being a member state of the union.

With the move, the country will also lose the expertise of thousands of highly skilled European professionals of the industry.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining

According to Beedle, the move might force the European Medicines Agency (EMA) to relocate, which would see many of the UK-based pharmaceutical companies relocating potentially to Ireland.

Beedle added: "We have such a powerful industry here that it seems like a huge error to leave, particularly at a time when our industrial output is growing at its fastest rate for four years, which has been heavily boosted by the pharma sector."

A Brexit would affect all UK businesses that utilise the expertise of European professionals.

The businesses would have to face a much larger administrative challenge as they would continue having a diverse workforce.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU